194 related articles for article (PubMed ID: 3296612)
1. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
[TBL] [Abstract][Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
Dousset-Faure I; Millan J; Decazes JM; Languillon J
Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of two regimens of combined chemotherapy of one year duration in multibacillary leprosy. Results after four and five years' follow-up.
Pattyn SR; André PS; Ferracci C; Baquillon G
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):297-303. PubMed ID: 6541198
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
Pattyn SR; Husser JA; Saint-André P
Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
[TBL] [Abstract][Full Text] [Related]
7. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
Cartel JL; Gallais JJ; Grosset JH
Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
[TBL] [Abstract][Full Text] [Related]
8. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
[TBL] [Abstract][Full Text] [Related]
9. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
Katoch K; Natarajan M; Bhatia AS; Yadav VS
Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
Cartel JL; Millan J; Guelpa-Lauras CC; Grosset JH
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):461-5. PubMed ID: 6686970
[TBL] [Abstract][Full Text] [Related]
11. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
12. Multidrug therapy in hospitalised leprosy cases.
Tiwari VD; Tutakne MA; Singh G; Dutta RK
Indian J Lepr; 1988 Jan; 60(1):71-6. PubMed ID: 3204277
[TBL] [Abstract][Full Text] [Related]
13. Problems of leprosy relapse in China.
Li HY
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
[TBL] [Abstract][Full Text] [Related]
14. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
[TBL] [Abstract][Full Text] [Related]
15. [Inadequate treatment in multibacillary leprosy and incubation times for relapses].
Pattyn SR; Husser JA; Janssens L; Grillone S; Bourland J
Acta Leprol; 1986; 4(4):495-9. PubMed ID: 3296622
[TBL] [Abstract][Full Text] [Related]
16. Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Cartel JL; Naudin JC
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):215-9. PubMed ID: 8046260
[TBL] [Abstract][Full Text] [Related]
17. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
Katoch K; Ramu G; Ramanathan U; Desikan KV
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
[TBL] [Abstract][Full Text] [Related]
19. [Histological progression of paucibacillary leprosy during treatment with various therapeutic regimens].
Pattyn SR; Husser JA; Janssens L; Nollet E
Acta Leprol; 1986; 4(4):501-4. PubMed ID: 3296623
[TBL] [Abstract][Full Text] [Related]
20. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
